Press "Enter" to skip to content

Cerba Research: collaboration boosts rare-disease discoveries

Belgium-based contract analysis group (CRO) Cerba Research gives core remedy experience in oncology, liver indications and infectious illness. Research groups in Belgium, South Africa, China and different international locations develop and deploy assays throughout APH, movement cytometry (16 colours globally) genomics, metabolomics, microbiology + virology and molecular biology.

Adrien Ko, medical advisor at Cerba Research, advised Outsourcing-Pharma that encouraging their researchers and different workers to work with one another and with clients results in higher outcomes.

Our subject matter experts enjoy open collaboration at the pace our clients require to optimize their therapeutic development and draw pivotal insights earlier​,” Ko stated. “We partner with these clients to speed up their research and development, whether it be by discussing, agreeing on and then delivering specialized custom assays and panels; assay transfer; or perhaps overcoming operational peculiarities baked into studies by way of challenges regarding stability of samples for testing​.”

Outsourcing-Pharma (OSP) mentioned Cerba Research’s work in oncology and different therapeutic areas, in addition to its patient-centric, collaborative method to discovery and growth.

OSP: What does “patient-driven insight” imply—how does it work, and why is it necessary?

AK: The concept behind “patient-driven insight” is to ​​place the affected person again on the coronary heart of illness administration. Patients need readability and better safety to enhance their well being journeys; that is achieved through the use of new applied sciences.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *